Dr. Aaron Benson, M.D

NPI: 1164508453
Total Payments
$5,708
2024 Payments
$2,184
Companies
32
Transactions
330
Medicare Patients
4,155
Medicare Billing
$509,889

Payment Breakdown by Category

Food & Beverage$5,618 (98.4%)
Education$89.81 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,618 328 98.4%
Education $89.81 2 1.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,455 88 $0 (2024)
Janssen Biotech, Inc. $922.33 58 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $872.51 66 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $405.85 25 $0 (2024)
Regeneron Healthcare Solutions, Inc. $245.95 8 $0 (2024)
Gilead Sciences, Inc. $224.60 12 $0 (2023)
UCB, Inc. $176.40 13 $0 (2019)
GENZYME CORPORATION $148.68 5 $0 (2023)
CONMED Corporation $136.34 2 $0 (2024)
Endogastric Solutions, Inc $121.04 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,184 105 ABBVIE INC. ($695.18)
2023 $1,294 83 AbbVie Inc. ($342.99)
2022 $566.96 38 ABBVIE INC. ($134.91)
2021 $408.14 30 Janssen Biotech, Inc. ($232.57)
2020 $188.24 8 Janssen Biotech, Inc. ($74.99)
2019 $266.80 19 Gilead Sciences, Inc. ($103.50)
2018 $628.85 37 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($157.09)
2017 $171.52 10 AbbVie, Inc. ($64.34)

All Payment Transactions

330 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/16/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.33 General
Category: IMMUNOLOGY
12/12/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $37.22 General
Category: INFLAMMATION AND IMMUNOLOGY
12/05/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $29.48 General
Category: IMMUNOLOGY
12/03/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.58 General
Category: INTERNAL MEDICINE
11/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.60 General
Category: Gastroenterology
11/19/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $12.44 General
Category: INTERNAL MEDICINE
11/19/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $5.93 General
Category: Immunology
11/18/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $24.18 General
Category: ONCOLOGY
11/18/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $13.10 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $26.14 General
Category: IMMUNOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $25.60 General
Category: INFLAMMATION AND IMMUNOLOGY
11/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $20.34 General
Category: IMMUNOLOGY
11/07/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $29.77 General
Category: IMMUNOLOGY
11/07/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $8.75 General
Category: VIROLOGY
10/31/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $33.00 General
Category: ENDOCRINOLOGY
10/31/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $7.98 General
Category: INTERNAL MEDICINE
10/30/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $15.90 General
Category: GASTROENTEROLOGY
10/29/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $24.68 General
Category: IMMUNOLOGY
10/24/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $39.29 General
Category: Immunology
10/22/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $29.44 General
Category: IMMUNOLOGY
10/22/2024 Sandoz Inc. HYRIMOZ (Biological) Food and Beverage In-kind items and services $20.52 General
Category: Immunology
10/08/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $22.66 General
Category: INTERNAL MEDICINE
10/08/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $14.50 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/08/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $8.26 General
Category: IMMUNOLOGY
10/01/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $44.58 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 1,026 1,082 $833,160 $130,437
2022 14 1,030 1,112 $807,964 $127,431
2021 14 1,115 1,170 $852,279 $138,930
2020 13 984 1,062 $634,435 $113,091
Total Patients
4,155
Total Services
4,426
Medicare Billing
$509,889
Procedure Codes
58

All Medicare Procedures & Services

58 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 188 189 $254,529 $43,049 16.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 176 221 $54,366 $21,839 40.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 119 119 $40,817 $14,678 36.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 178 178 $226,950 $14,229 6.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 35 35 $36,260 $7,023 19.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 81 82 $87,986 $6,457 7.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 91 95 $16,625 $6,246 37.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 22 22 $22,836 $4,429 19.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 22 22 $8,822 $3,228 36.6%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 19 19 $19,722 $2,664 13.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 24 29 $4,176 $1,894 45.4%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 22 22 $18,590 $1,613 8.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 13 13 $3,653 $1,455 39.8%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 13 13 $37,219 $1,443 3.9%
91200 Measurement of liver stiffness Facility 2023 12 12 $444.00 $97.02 21.9%
36415 Insertion of needle into vein for collection of blood sample Office 2023 11 11 $165.00 $92.40 56.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 177 177 $238,242 $38,121 16.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 175 218 $46,998 $20,501 43.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 134 134 $45,962 $16,339 35.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 180 180 $229,628 $15,454 6.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 32 32 $33,152 $6,529 19.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 89 99 $14,272 $6,422 45.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 70 71 $76,183 $4,946 6.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 30 31 $12,206 $4,628 37.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 44 67 $9,408 $3,967 42.2%

About Dr. Aaron Benson, M.D

Dr. Aaron Benson, M.D is a Internal Medicine healthcare provider based in Mt Prospect, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164508453.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Benson, M.D has received a total of $5,708 in payments from pharmaceutical and medical device companies, with $2,184 received in 2024. These payments were reported across 330 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,618).

As a Medicare-enrolled provider, Benson has provided services to 4,155 Medicare beneficiaries, totaling 4,426 services with total Medicare billing of $509,889. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology
  • Location Mt Prospect, IL
  • Active Since 10/28/2006
  • Last Updated 04/26/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1164508453

Products in Payments

  • STELARA (Biological) $820.24
  • ENTYVIO (Biological) $655.42
  • RINVOQ (Biological) $439.80
  • SKYRIZI (Biological) $434.90
  • DUPIXENT (Biological) $394.63
  • XIFAXAN (Drug) $256.66
  • Entyvio (Biological) $194.03
  • Humira (Biological) $186.11
  • Cimzia (Drug) $176.40
  • CREON (Drug) $150.09
  • CONMED BILIARY (Device) $136.34
  • ESOPHYX (Device) $121.04
  • OCALIVA (Drug) $112.13
  • UCERIS (Drug) $112.09
  • SUCRAID (Drug) $98.57
  • ZEPOSIA (Drug) $94.64
  • TREMFYA (Drug) $89.80
  • XELJANZ (Drug) $88.50
  • LINZESS (Drug) $75.48
  • HUMIRA (Biological) $69.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Mt Prospect